Cuts FY25 adjusted EBITDA view to $195M from $205M-$215M. The company said, “The Company is updating its full-year outlook, primarily due to third-quarter results being lower than expected and the effect of the rising level of macroeconomic uncertainty on the Company’s end markets, as well as the expected impact of tariffs in the fourth quarter. Revenue is now expected to be approximately $895 million and Adjusted EBITDA is now expected to be approximately $195 million. The Company now expects capital expenditures to be approximately $100 million, reflecting the lower Adjusted EBITDA and pull-forward of some level of integration capex into fiscal 2025.”
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NEOG:
- Options Volatility and Implied Earnings Moves Today, April 09, 2025
- Neogen reports Q3 adjusted EPS 10c, consensus 12c
- Neogen Announces Successful Loan Refinancing
- Options Volatility and Implied Earnings Moves This Week, April 07 – April 11, 2025
- NEOG Earnings Report this Week: Is It a Buy, Ahead of Earnings?